Mass General Brigham shared a post on LinkedIn:
“When John Mulattieri was diagnosed with pancreatic cancer in March 2026, he wasn’t sure what his future would look like.
Now, with daraxonrasib, a new treatment for pancreatic cancer available at Mass General Brigham Cancer Institute, he is looking ahead with renewed hope and optimism.”
Proceed to the video attached to the post.
Other posts about Mass General Brigham on OncoDaily.